Mark is the founder of PHMR and has developed the company into a successful health economics, pricing and market access consultancy working with a range of top 10 pharma companies. He has a vast amount of experience in the health economics, pricing, reimbursement and market access fields. He also possesses decades of experience with major international pharmaceutical companies and previous work in senior economics research positions.

Jeremy has extensive experience in leading large national, regional and global commercial operations in major pharmaceutical companies. Jeremy brings a wealth of experience to his role at PHMR, providing strategic advice to our clients on commercialisation at all stages of product development, from initial clinical development, to launch, to late lifecycle. He is an expert in commercial strategy development and operational execution. Most recently he led the launches of multiple new diabetes therapies across Europe, Japan, Canada and Australia including novel proteins and biosimilars.

Koonal is a health economist with expertise in stated preference methods, the measurement and valuation of health, and the use of social value judgements in HTA decision making. He has published extensively on HTA policy, particularly on the assessment of cancer and end of life treatments. He has led research and consulting projects for a diverse range of funders and clients including global pharmaceutical companies, health care providers, policy makers, charities and research foundations. Koonal is a member of the EuroQol Group (an international network of researchers that developed the EQ-5D family of instruments) and currently serves on the Group’s Executive Committee.

Kevin is an experienced consultant who has responsibility as a project director managing teams of reviewers in our Newcastle Office. He specialises in systematic literature review methodology and delivers reports to clients that meet international HTA and Cochrane standards. Kevin has completed reviews in clinical efficacy, network meta-analysis, diagnostic accuracy, economic evaluations, health-related quality of life, HTA submissions, guidelines/treatment pathways, and disease epidemiology over a wide range of therapeutic areas.

Megan has extensive experience working across a variety of stages of the drug development process, ranging from analysis of Phase I and III clinical trial data to conducting systematic literature reviews and network meta-analyses for health technology assessment submissions. Megan is familiar with a wide range of common and novel statistical methods used in the pharmaceutical industry and has experience using both frequentist and Bayesian frameworks. She is also proficient with a wide range of programming languages, including SAS, R and WinBUGs.

Gintare’s journey at PHMR began in 2013 when she joined the company as Administrative Assistant to help establish the Newcastle upon Tyne (UK) office. Currently she is part of the team providing support to the growth of the company by keeping HR operations aligned to the company values. Gintare is passionate about her role and she strongly believes that positive working relationships are the foundation for any kind of success. In her spare time Gintare attends art exhibitions, goes on contemporary theatre breaks, reads world literature and enjoys outdoor trips, especially if foraging is on the agenda.

Dave has considerable experience in the information and library field supporting health research. He is responsible for designing literature searches and strategies to support the wide variety of projects and research that PHMR undertakes and managing the results of searches using reference management software. He has run literature searches to support numerous reviews including NICE single and multiple technology assessments, Cochrane reviews, Public Health Research Council projects, and British Thoracic Society clinical guidelines.

Persefoni has a strong background in the field of medical writing with extensive experience in proofreading, quality assessment of publications and data extractions. Since starting work at PHMR, she has been involved in a range of projects, including preparation of manuscripts, pragmatic literature reviews, early pipeline assessments, global value dossiers and health technology assessment reviews. Persefoni has worked in a range of disease areas, including musculoskeletal diseases, gastrointestinal diseases, mental disorders and haematologic malignancies.

Thomas is a statistician and has been involved in a variety of projects using real-world data to inform decision making and insight. He has worked with a variety of frequentist and Bayesian modelling approaches with complex spatio-temporal data using state-of-the-art MCMC fitting procedures. He is proficient in R and Python.
Currently, he is completing his PhD at Imperial College London after having a varied background in mathematics and statistics with applications in various areas. He has presented at conferences and workshops nationally and internationally and is published in peer-reviewed journals.

Aurelie joined PHMR after successfully completing an MSc in Health Economics at the University of York. She has experience in decision modelling and developing and adapting models for local HTA agencies. Prior to joining PHMR, she conducted policy evaluative research in academia gaining experience in data analysis using econometrics methods. Additionally, she holds an MSc in Chemical Engineering and has previous work experience in marketing in the pharmaceutical industry.

Rachel has been involved in a range of projects at PHMR, including systematic and pragmatic literature reviews, advisory boards, HTA submissions and the preparation of a wide range of value communication documents. She has experience in the therapeutic areas of IBD, AAV and CKD, and extensive experience in nutraceuticals research prior to joining PHMR. She has prepared manuscripts for publication in high impact peer-reviewed research journals and presented at international conferences.

Caroline has been involved in conducting systematic and pragmatic literature reviews of clinical efficacy, economic evaluations, health-related quality of life and burden of illness, to support market access strategies. She has experience in all aspects of the review process, including developing protocols, screening, data extraction and report writing. She has also conducted primary market research with payers and KOLs to assess market access opportunities. Before joining PHMR, Caroline worked in academia in public health research, where she performed observational and interventional studies, as well as systematic and scoping reviews.

Catherine’s main responsibility at PHMR is focussed on undertaking pragmatic and systematic literature reviews. Prior to joining PHMR, Catherine worked for 15 years in clinical trial management in an academic and commercial trial environment and was involved in Phase II/III trials across different therapeutic areas. She has developed skills in data monitoring, communication with commercial and academic sponsors and preparing/submitting complex study documentation. During her PhD, she prepared manuscripts for publication and has presented at international conferences.